| Line Item | Jun 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INVESTMENT INCOME | |||||||||||||||
| Interest income | — | ||||||||||||||
| Payment-in-kind interest income | |||||||||||||||
| Other income | |||||||||||||||
| Total Investment Income | |||||||||||||||
| OPERATING EXPENSES | |||||||||||||||
| Management fees | |||||||||||||||
| Valuation fees | |||||||||||||||
| Administrative services expenses | |||||||||||||||
| Income incentive fees | |||||||||||||||
| Professional fees | |||||||||||||||
| Directors' fees | |||||||||||||||
| Insurance expense | |||||||||||||||
| Interest expense and other fees | |||||||||||||||
| Income tax expense | |||||||||||||||
| Other general and administrative expenses | |||||||||||||||
| Total Operating Expenses | |||||||||||||||
| Income incentive fee waiver | |||||||||||||||
| Total Operating Expenses, net of fee waivers | |||||||||||||||
| Net Investment Income | |||||||||||||||
| Net realized (loss) gain on investments | — | ||||||||||||||
| Net realized (loss) gain on foreign currency translations | |||||||||||||||
| Net change in unrealized (depreciation) appreciation on investments | |||||||||||||||
| Net change in unrealized appreciation (depreciation) on foreign currency translations | |||||||||||||||
| Net Increase in Net Assets Resulting from Operations | |||||||||||||||
| Net Investment Income Per Share - basic | |||||||||||||||
| Net Investment Income Per Share - diluted | |||||||||||||||
| Net Increase in Net Assets Resulting from Operations Per Share Basic (in dollars per share) | |||||||||||||||
| Net Increase in Net Assets Resulting from Operations Per Share Diluted (in dollars per share) | |||||||||||||||
| Distributions Per Share-basic and diluted | — |